Danish pharma giant Novo to use Anthropic’s Claude to advance AI drug discovery 😊
Danish pharma giant Novo to use Anthropic’s Claude to advance AI drug discovery 😊
Cikk tartalma röviden
Danish pharmaceutical company Novo has teamed up with Anthropic to leverage AI in drug development, aiming to accelerate the creation of new medicines. CEO Mike Doustdar emphasized that this collaboration will enhance their R&D capabilities and open new avenues in understanding human biology. The partnership follows Novo's previous use of AI tools, including OpenAI's GPT-Rosalind, to streamline drug research processes.
Danish pharmaceutical company Novo has teamed up with Anthropic to leverage AI in drug development, aiming to accelerate the creation of new medicines. CEO Mike Doustdar emphasized that this collaboration will enhance their R&D capabilities and open new avenues in understanding human biology. The partnership follows Novo's previous use of AI tools, including OpenAI's GPT-Rosalind, to streamline drug research processes.